Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism

Yue Shan Lin, Shaw Jenq Tsai, Ming Wei Lin, Cheng Ta Yang, Mei Feng Huang, Meng Hsing Wu

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Problem Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder. This study was to evaluate whether insulin receptor substrate (IRS)-2 Gly1057Asp polymorphism influences chronic inflammatory parameters in Taiwanese patients with PCOS. Method of study DNA was extracted from whole blood samples for genotyping and detection of IRS-2 Gly1057Asp polymorphism in 129 PCOS women and 109 control women. Ninety-seven PCOS women accepted metformin treatment for 3months, and low-grade chronic inflammatory markers were assessed. Results The levels of IL-6 were significantly elevated in PCOS women compared with normal women. Among allelic variant of IRS-2, concentrations of IL-6 were greater in IRS-2 homozygous Asp population. Treatment with metformin significantly reduced IL-6, especially in PCOS patients with IRS-2 homozygous Asp variant. Conclusion The results showed that IL-6 may be an early low-grade chronic inflammatory marker among PCOS patients with IRS-2 polymorphism in Taiwanese population. This pharmacologic study in IRS-2 polymorphism may provide more information for preventing long-term complications in PCOS.

Original languageEnglish
Pages (from-to)527-533
Number of pages7
JournalAmerican Journal of Reproductive Immunology
Volume66
Issue number6
DOIs
Publication statusPublished - Dec 2011

Fingerprint

Insulin Receptor Substrate Proteins
Polycystic Ovary Syndrome
Interleukin-6
Metformin
Viperidae
Population
DNA
Therapeutics

Keywords

  • Chronic inflammatory marker
  • Insulin receptor substrate-2
  • Interleukin-6
  • Metformin
  • Polycystic ovary syndrome
  • Polymorphism

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism. / Lin, Yue Shan; Tsai, Shaw Jenq; Lin, Ming Wei; Yang, Cheng Ta; Huang, Mei Feng; Wu, Meng Hsing.

In: American Journal of Reproductive Immunology, Vol. 66, No. 6, 12.2011, p. 527-533.

Research output: Contribution to journalArticle

Lin, Yue Shan ; Tsai, Shaw Jenq ; Lin, Ming Wei ; Yang, Cheng Ta ; Huang, Mei Feng ; Wu, Meng Hsing. / Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism. In: American Journal of Reproductive Immunology. 2011 ; Vol. 66, No. 6. pp. 527-533.
@article{353bc97b69544dd5b8b68ed5a798079b,
title = "Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism",
abstract = "Problem Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder. This study was to evaluate whether insulin receptor substrate (IRS)-2 Gly1057Asp polymorphism influences chronic inflammatory parameters in Taiwanese patients with PCOS. Method of study DNA was extracted from whole blood samples for genotyping and detection of IRS-2 Gly1057Asp polymorphism in 129 PCOS women and 109 control women. Ninety-seven PCOS women accepted metformin treatment for 3months, and low-grade chronic inflammatory markers were assessed. Results The levels of IL-6 were significantly elevated in PCOS women compared with normal women. Among allelic variant of IRS-2, concentrations of IL-6 were greater in IRS-2 homozygous Asp population. Treatment with metformin significantly reduced IL-6, especially in PCOS patients with IRS-2 homozygous Asp variant. Conclusion The results showed that IL-6 may be an early low-grade chronic inflammatory marker among PCOS patients with IRS-2 polymorphism in Taiwanese population. This pharmacologic study in IRS-2 polymorphism may provide more information for preventing long-term complications in PCOS.",
keywords = "Chronic inflammatory marker, Insulin receptor substrate-2, Interleukin-6, Metformin, Polycystic ovary syndrome, Polymorphism",
author = "Lin, {Yue Shan} and Tsai, {Shaw Jenq} and Lin, {Ming Wei} and Yang, {Cheng Ta} and Huang, {Mei Feng} and Wu, {Meng Hsing}",
year = "2011",
month = "12",
doi = "10.1111/j.1600-0897.2011.01059.x",
language = "English",
volume = "66",
pages = "527--533",
journal = "American Journal of Reproductive Immunology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Interleukin-6 as an Early Chronic Inflammatory Marker in Polycystic Ovary Syndrome with Insulin Receptor Substrate-2 Polymorphism

AU - Lin, Yue Shan

AU - Tsai, Shaw Jenq

AU - Lin, Ming Wei

AU - Yang, Cheng Ta

AU - Huang, Mei Feng

AU - Wu, Meng Hsing

PY - 2011/12

Y1 - 2011/12

N2 - Problem Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder. This study was to evaluate whether insulin receptor substrate (IRS)-2 Gly1057Asp polymorphism influences chronic inflammatory parameters in Taiwanese patients with PCOS. Method of study DNA was extracted from whole blood samples for genotyping and detection of IRS-2 Gly1057Asp polymorphism in 129 PCOS women and 109 control women. Ninety-seven PCOS women accepted metformin treatment for 3months, and low-grade chronic inflammatory markers were assessed. Results The levels of IL-6 were significantly elevated in PCOS women compared with normal women. Among allelic variant of IRS-2, concentrations of IL-6 were greater in IRS-2 homozygous Asp population. Treatment with metformin significantly reduced IL-6, especially in PCOS patients with IRS-2 homozygous Asp variant. Conclusion The results showed that IL-6 may be an early low-grade chronic inflammatory marker among PCOS patients with IRS-2 polymorphism in Taiwanese population. This pharmacologic study in IRS-2 polymorphism may provide more information for preventing long-term complications in PCOS.

AB - Problem Polycystic ovary syndrome (PCOS) is a common gynecological endocrine disorder. This study was to evaluate whether insulin receptor substrate (IRS)-2 Gly1057Asp polymorphism influences chronic inflammatory parameters in Taiwanese patients with PCOS. Method of study DNA was extracted from whole blood samples for genotyping and detection of IRS-2 Gly1057Asp polymorphism in 129 PCOS women and 109 control women. Ninety-seven PCOS women accepted metformin treatment for 3months, and low-grade chronic inflammatory markers were assessed. Results The levels of IL-6 were significantly elevated in PCOS women compared with normal women. Among allelic variant of IRS-2, concentrations of IL-6 were greater in IRS-2 homozygous Asp population. Treatment with metformin significantly reduced IL-6, especially in PCOS patients with IRS-2 homozygous Asp variant. Conclusion The results showed that IL-6 may be an early low-grade chronic inflammatory marker among PCOS patients with IRS-2 polymorphism in Taiwanese population. This pharmacologic study in IRS-2 polymorphism may provide more information for preventing long-term complications in PCOS.

KW - Chronic inflammatory marker

KW - Insulin receptor substrate-2

KW - Interleukin-6

KW - Metformin

KW - Polycystic ovary syndrome

KW - Polymorphism

UR - http://www.scopus.com/inward/record.url?scp=81155131055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=81155131055&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0897.2011.01059.x

DO - 10.1111/j.1600-0897.2011.01059.x

M3 - Article

C2 - 21801267

AN - SCOPUS:81155131055

VL - 66

SP - 527

EP - 533

JO - American Journal of Reproductive Immunology

JF - American Journal of Reproductive Immunology

SN - 1046-7408

IS - 6

ER -